This study examines the expression levels of certain proteins (DNMT1, DNMT3A, and DNMT3B) in tumor tissue, using immunohistochemistry to assess whether these protein levels are linked to the risk of cancer recurrence or mortality. This evidence concerns the gene DNMT3A and cancer.